MBOT logo

Microbot Medical Inc. Stock Price

NasdaqCM:MBOT Community·US$162.5m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 18 Fair Values set on narratives written by author

MBOT Share Price Performance

US$2.42
1.45 (148.43%)
US$2.42
1.45 (148.43%)
Price US$2.42

MBOT Community Narratives

There are no narratives available yet.

Snowflake Analysis

Flawless balance sheet with slight risk.

4 Risks
1 Reward

Microbot Medical Inc. Key Details

US$0

Revenue

US$0

Cost of Revenue

US$0

Gross Profit

US$12.7m

Other Expenses

-US$12.7m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
-0.19
0%
0%
0%
View Full Analysis

About MBOT

Founded
2010
Employees
20
CEO
Harel Gadot
WebsiteView website
microbotmedical.com

Microbot Medical Inc. is a medical device company that focuses on transforming endovascular procedures through advanced robotic technology. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, endovascular, and neurovascular operations. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system; and Emory University, in connection with autonomous robotics in endovascular procedures. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts

Recent MBOT News & Updates

Recent updates

No updates